Showing 8,841 - 8,860 results of 36,201 for search '(( 2 de decrease ) OR ( 50 ((((nn decrease) OR (mean decrease))) OR (a decrease)) ))', query time: 1.00s Refine Results
  1. 8841

    Pyridoxine chlorhydrate forced degradation. by Marine Bonino (21156835)

    Published 2025
    “…In compounding practice, a medication can be done extemporaneously, leading to a risk of error. …”
  2. 8842

    Thiamine chlorhydrate forced degradation. by Marine Bonino (21156835)

    Published 2025
    “…In compounding practice, a medication can be done extemporaneously, leading to a risk of error. …”
  3. 8843

    Riboflavine forced degradation. by Marine Bonino (21156835)

    Published 2025
    “…In compounding practice, a medication can be done extemporaneously, leading to a risk of error. …”
  4. 8844

    Biotin forced degradation. by Marine Bonino (21156835)

    Published 2025
    “…In compounding practice, a medication can be done extemporaneously, leading to a risk of error. …”
  5. 8845

    Characteristics of dexmedetomidine use. by Shi-Yuan Yu (17054536)

    Published 2023
    “…Forty-five percent of patients had ≥50% days of rousable sedation. Hypotension occurred in 85% of patients. …”
  6. 8846

    Baseline characteristics. by Shi-Yuan Yu (17054536)

    Published 2023
    “…Forty-five percent of patients had ≥50% days of rousable sedation. Hypotension occurred in 85% of patients. …”
  7. 8847
  8. 8848
  9. 8849
  10. 8850

    Effect of BNN27 treatment on stride length and width in male and female mice. by Kelly E. Glajch (3204465)

    Published 2016
    “…<p>Male Tg vehicle-treated mice exhibited a decrease in stride length (a, left) at p115 (p = 0.0136, Mann-Whitney <i>U</i> test) and stride width (b, left) at p95 (p = 0.0202, Mann-Whitney <i>U</i> test) relative to Wt vehicle-treated mice. …”
  11. 8851

    Promoting Fc:Fc interactions alleviates CDC sensitivity to target and mCRP expression. by Rob N. de Jong (843705)

    Published 2016
    “…Eight days after tumor cell injection, mice were randomized at an average tumor volume of 85 mm<sup>3</sup> per group and treated with 50 μg IgG1 antibody. Tumor volumes were monitored over time and depicted as average tumor volume ± standard error of the mean (SEM) (left panel), and as Kaplan-Meier curves with time to progression cutoff set at a tumor volume of >700 mm<sup>3</sup> (right panel).…”
  12. 8852
  13. 8853

    Summary of the experimental design. by Nagwa Ibrahim Shehata (17319689)

    Published 2023
    “…The third and fourth groups received a single daily dose of 50 mg/kg Safr (intraperitoneal) and 1 mg/kg Cands (oral), respectively. …”
  14. 8854

    Percentage positive tests, tests turnaround times (24h-48h) and cumulative cases are reported from March 17, 2020 to November 28, 2020 in Toronto. by Elena Aruffo (11981366)

    Published 2022
    “…<p>The percentage positive tests decrease from May 31 to August 24, when it starts increasing, showing, however a magnitude smaller than the first wave in March. …”
  15. 8855
  16. 8856

    DIP grouping and aggregation system. by Chenxuan Zhu (22622476)

    Published 2025
    “…Total costs in the non-surgical group showed a decreasing trend post-DIP intervention (β<sub>1</sub> + β<sub>3</sub> = −3.12). …”
  17. 8857

    DIP coding logic example. by Chenxuan Zhu (22622476)

    Published 2025
    “…Total costs in the non-surgical group showed a decreasing trend post-DIP intervention (β<sub>1</sub> + β<sub>3</sub> = −3.12). …”
  18. 8858
  19. 8859
  20. 8860